NFE2L2 and viral infectious disease: This suggests that Nrf2 activation could provide a multifaceted therapeutic approach, combining antiviral activity with the cytoprotective effects of the Nrf2 pathway, offering potential benefits in treating COVID-19 and other viral infections [17].